Metabolic Peptide
Tesamorelin
GHRH analog studied in lipid metabolism and visceral adipose research.
$120.00
Free shipping on orders over $300 · Same-day dispatch before 2PM EST
Select Option
Volume Discounts
Don't forget your reconstitution solution
Bacteriostatic Water 30mL
$14.99
Purchase Options
Lab Verified
HPLC-MS + endotoxin
Same-Day Ship
Orders by 2PM EST
Damage Coverage
Free replacement
Discreet Packaging
Plain outer box
Research Use Only
Not for human or veterinary consumption. For laboratory and in-vitro research purposes only.
Description
Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH) used in laboratory studies of lipid metabolism.
Provided as a lyophilized white powder for reconstitution. For research use only.
Reconstitution
Reconstitute with bacteriostatic water in your preferred ratio. Store reconstituted vials refrigerated (2–8 °C) and use within recommended timeframes for your protocol.
Storage
Unreconstituted lyophilized powder stable at room temperature for short periods; refrigerate (2–8 °C) for long-term storage. Avoid repeat freeze/thaw cycles.
- Dose
- 5mg
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Storage
- Refrigerate after reconstitution
- Origin
- USA — synthesized & shipped domestically
- Testing
- HPLC-MS, MALDI, endotoxin screen
Research Overview
Tesamorelin is a stabilized 44-amino-acid analog of growth hormone–releasing hormone (GHRH). A trans-3-hexenoic acid modification on the N-terminus protects it from rapid enzymatic degradation, giving it a notably longer research half-life than native GHRH(1-44).
It is widely used in laboratory studies of the somatotropic axis, visceral adipose tissue biology, and pulsatile GH release dynamics.
Mechanism of Action
Tesamorelin binds the GHRH receptor on anterior pituitary somatotrophs in research models, stimulating endogenous pulsatile growth hormone release while preserving the natural feedback architecture of the GH/IGF-1 axis.
Research Applications
- GHRH receptor pharmacology
- Visceral adipose research models
- Lipid metabolism studies
- GH/IGF-1 axis signaling
Reconstitution & Handling
Certificate of Analysis
Lot / Batch
QP-2025-1573
- Product
- Tesamorelin
- Manufacture date
- 2025-10-26
- Test date
- 2025-10-29
- Expiration
- 2028-10-26
- Appearance
- White to off-white lyophilized powder
- Identity
- Confirmed — matches reference standard
- Purity (HPLC)
- 99.70%
- Water content (KF)
- 1.70%
- Endotoxin (LAL)
- < 0.08 EU/mg
- Bioburden
- < 1 CFU / vial
- Analytical methods
- RP-HPLC, ESI-MS, MALDI-TOF, LAL endotoxin assay
- Released by
- QPUSA Quality Assurance Lab
